SEARCH

SEARCH BY CITATION

References

  • 1
    Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996;42, 697 705
  • 2
    Leach CL. Improved delivery of inhaled steroids to the large and small awirways. Respir Med 1998;92(Suppl A)3 8
  • 3
    Milanowski J, Qualtrough J, Perrin VL. Inhaled beclomethasone (BDP) with a non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma. Respir Med 1999;93, 245 251
  • 4
    Lipworth BJ & Wilson AM. Dose response to inhaled corticosteroids: benefits and risks. Sem Respir Crit Care Med 1998;19, 625 646
  • 5
    Busse W, Colice G, Hannon S CFC-BDP require 2. 6 times the dose to achieve equivalent improvement in FEV1 as HFA-BDP. Am J Respir Crit Care Med 1998;157: A405
  • 6
    Davies RJ, Stampone P, O’Connor BJ Hydrofluoroalkane-34a dipropionate extra fine aerosol beclomethasone provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the dose. Respir Med 1998;92(Suppl A)23 31
  • 7
    Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J Hydrofluoroalkane-134a beclomethasone dipropionate, 400μg is as effective as chlorofluorocarbon beclomethasone dipropionate 800μg for the treatment of moderate asthma. Chest 1999;15, 343 335
  • 8
    Toogood JH, Baskerville J, Jennings B, Neville M, Lefcoe NM, Johannsson SA. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984;129, 723 729